IVOG Fact Sheet: Vanguard S&P Mid-Cap 400 Growth ETF
Share
$132.08
close, Nov 18, 2026
Over the year to Nov 18, 2026, IVOG returned +14.6% in total and charged 0.10% a year.
- 1-year total return
- +14.6%
- IJK +14.6% to Nov 18, 2026
- Expense ratio
- 0.10%
- a year
- Net assets
- $1.7bn
- on Oct 31, 2026
Growth of $10,000, 1 year
IVOG $11,464 +14.6% · IJK $11,456 +14.6% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−2.5%
3 months−8.7%
Year to date+9.9%
1 year+14.6%
3 years+48.2%
5 years+27.5%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Okta Inc1.99%
TechnipFMC PLC1.55%
United Therapeutics Corp1.48%
ATI Inc1.30%
XPO Inc1.28%
Tenet Healthcare Corp1.27%
Roku Inc1.18%
nVent Electric PLC1.18%
Royal Gold Inc1.12%
Woodward Inc1.04%
IVOG top ten by weight, 13.4% of the fund, of its 247 equity positions, from the holdings filed for Oct 31, 2026.
Facts
Equity fund · Tracks the S&P MidCap 400 Growth Index · First traded Sep 9, 2010 · Benchmark S&P MidCap 400 Growth Index, measured by IJK, which tracks the same index